Experts on Call

Quick, confidential consulation with industry experts

Patient Loyalty
Chris Dowd
Chris Dowd is Executive Vice President at ConnectiveRx. Chris has 25 years of pharma experience including Sales, Operations, Managed Care, and Marketing positions, including Executive Director and VP levels in Pfizer, Esprit Pharma, and Allergan.
Brand Engagement
Don Feiler
Don Feiler is Partner/Chief Digital Officer at Calcium. Don brings a wealth of experience scoping, designing, creating, and deploying online applications and multimedia for the pharmaceutical and healthcare industries. He has worked with Merck, Pfizer, Novartis, Novo Nordisk, Janssen, and many others over the course of his 20-year career.
Success Coach
Bud Bilanich
Bud Bilanich, The Common Sense Guy, is a success coach, motivational speaker, author and blogger. He is a faculty member at the Daniels College of Business at the University of Denver where he teaches courses in Organizational Dynamics and Human Capital Management. Bud has written five books on career and life success, which are the basis of his Common Sense Success System.
Health Psychology
John Weinman, PhD
John Weinman, PhD is Head of Health Psychology at Atlantis Healthcare and Professor of Psychology at King’s College, London. Professor Weinman is recognized as one of the founders of modern health psychology and respected as a preeminent global thought leader in the field. His main research areas are cognition and health, communication and decision-making in healthcare, and self-management and self-regulation in chronic illness.
Medication Adherence
Rick Ratliff
Rick Ratliff is President and Chief Commercial Officer at ConnectiveRx. ConnectiveRx connects prescribers, pharmacists, and consumers to simplify how people get and stay on medications by providing information, savings, and access to medications people need.
Patient-Provider Dialogue
Jessica Brueggeman
Jessica Brueggeman is SVP, Health Behavior Group at MicroMass Communications, Inc. Jessica leads a team of behaviorists in applying behavior change strategies to health communication programs. Recently, her role expanded to include development of new products and services for health systems and ACOs.
Rare Disease & Orphan Drug Commercialization
Amy Grogg
Amy Grogg, PharmD is Senior Vice President of Strategy and Commercialization at AmerisourceBergen Specialty Group. Dr. Grogg develops strategies to advance AmerisourceBergen’s leadership in the pharmaceutical services industry and position the company as the preferred commercialization partner for specialty pharmaceutical manufacturers. She also holds operational responsibility for Xcenda, part of AmerisourceBergen, which provides strategic consulting services for life sciences manufacturers commercializing products in the U.S., Germany, and key global markets.
Authentic Patient Voice
Brenda Snow
Brenda Snow is Founder & CEO at Snow Companies. Brenda is widely regarded as the leading pioneer in patient engagement. Her agency Snow Companies is active globally and has helped over 50 businesses representing more than 100 brands become more patient centric and more successful. The company provides various patient-centric initiatives that include, among others, the Patient Ambassador platform, call center support, and patient research.
HCP Engagement
Erik Dalton
Erik Dalton is Executive Vice President at Healthcasts. Erik has helped spearhead the evolution of Healthcasts since 2005, from a video engagement company to a multichannel, on-demand educational experience for physicians. His leadership drives market growth and product innovation for the company.
DTC Marketing
Richard Meyer
Richard Meyer has worked in healthcare marketing for more than 12 years and is the author of www.worldof and www.newmediaand He is the Director of Online Strategic Solutions.
Life Sciences Medical Strategy
Jeffrey D. Erb
Jeffrey D. Erb is President at Healix. Jeffrey leads the healthcare division of IPG Mediabrands. For over 16 years, Jeff has defined new strategies for clients in both HCP and Consumer marketing from media and analytics to digital and pricing strategies.
Back to top